TEAM plc hitting the ground running with new division
15 December 2023
Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture the attention of investors with its robust portfolio of therapeutics and promising financial metrics. Headquartered in Thousand..
Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its impressive market cap of $178.73 billion and a robust array of healthcare products..
Novartis AG (NYSE: NVS), a powerhouse in the healthcare sector, operates within the global pharmaceutical landscape. With its market capitalization standing at an impressive $266.8 billion, Novartis continues to be..
Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector specializing in medical devices, offers a compelling investment case with a significant upside potential of 42.5%. As the..
Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its expansive market cap of $650.65 billion. As a major player in the..
Kamada Ltd. (NASDAQ: KMDA), an Israel-based healthcare company specializing in plasma-derived protein therapeutics, is garnering attention from investors due to its robust revenue growth and promising analyst ratings. With a..
Rapport Therapeutics, Inc. (RAPP), a clinical-stage biotechnology firm headquartered in Boston, Massachusetts, is gaining traction among investors due to its promising pipeline and significant potential upside. Operating within the healthcare..
AngioDynamics, Inc. (NASDAQ: ANGO) is garnering attention among healthcare investors as it stands poised for potential growth, driven by strategic advancements in medical technology. With a market capitalization of $635.28..
Prothena Corporation plc (NASDAQ: PRTA), a biotechnology firm headquartered in Dublin, Ireland, is capturing the attention of investors with an impressive potential upside of 152.96%. Specializing in the development of..
Investors looking for high potential in the biotechnology sector should take note of Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotech company with a strong focus on developing targeted therapies for..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is capturing the attention of savvy investors in the biotechnology sector with its groundbreaking work in monoclonal antibody therapeutics. As a clinical-stage biopharmaceutical company, Oruka..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing investor attention with its promising potential for substantial upside. As a clinical-stage biopharmaceutical firm, Oric focuses on developing innovative therapies to tackle cancer..
Orthofix Medical Inc. (NASDAQ: OFIX) is positioning itself as a compelling opportunity within the healthcare sector, specifically in the medical devices industry. With a market capitalization of approximately $351.93 million,..
Abivax SA (ABVX), a clinical-stage biotechnology company headquartered in Paris, France, is capturing the attention of investors with a substantial potential upside of 54.22%. Specializing in the development of therapeutics..
Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services sector, presents a captivating case for investors willing to delve into a company with significant upside potential..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is making waves in the healthcare sector, especially within the niche of specialty and generic drug manufacturing. With a market capitalization of $4.33 billion, this..
COMPASS Pathways Plc (CMPS) is making waves in the healthcare sector with its innovative approach to mental health treatment. As a biotechnology company headquartered in London, COMPASS Pathways is pioneering..
Investors with an eye on the biotechnology sector may find Upstream Bio, Inc. (NASDAQ: UPB) an intriguing prospect, especially given its substantial potential upside of 486.49%. Despite its current challenges,..
Standard BioTools Inc. (NASDAQ: LAB), a player in the healthcare sector with a focus on medical devices, is drawing attention from investors with a noteworthy potential upside of approximately 84.93%,..
